KeifeRx

Restore recycling capability of cells
Remove buildup of toxic protein
Reduce neuroinflammation
Repair vascular damage
Recover patient wellbeing

Our Mission

KeifeRx is a clinical stage biopharma company dedicated to improving the lives of dementia patients and their loved ones by slowing the progression of neurodegenerative diseases and improving cognition.

About Us

Our Science

KeifeRx is building upon its extensive clinical experience in neurodegenerative diseases to advance kinase Inhibitors that attack neurodegenerative diseases at their root cause. Our drug candidates restore autophagy and attack the three pillars of neurodegenerative diseases; microglial-mediated neuroinflammation, toxic protein build up, and vascular damage while restoring cognition. Our robust pipeline of drug candidates is designed for superior brain penetration and potency, representing a potential new generation of treatments for patients in urgent need.

Learn More

Older woman in red against a blue and teal background

Our Pipeline

KeifeRx is advancing second generation kinase inhibitors targeting neurodegenerative diseases including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson’s disease and dementia (PDD) and frontotemporal dementia.

Learn More